0001562180-24-004084.txt : 20240516 0001562180-24-004084.hdr.sgml : 20240516 20240516160043 ACCESSION NUMBER: 0001562180-24-004084 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240514 FILED AS OF DATE: 20240516 DATE AS OF CHANGE: 20240516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lim Bryant David CENTRAL INDEX KEY: 0001752888 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39527 FILM NUMBER: 24955355 MAIL ADDRESS: STREET 1: C/O IDERA PHARMACEUTICALS, INC. STREET 2: 505 EAGLEVIEW BLVD., SUITE 212 CITY: EXTON STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Prelude Therapeutics Inc CENTRAL INDEX KEY: 0001678660 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 811384762 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 175 INNOVATION BOULEVARD CITY: WILMINGTON STATE: DE ZIP: 19805 BUSINESS PHONE: (302) 467-1280 MAIL ADDRESS: STREET 1: 175 INNOVATION BOULEVARD CITY: WILMINGTON STATE: DE ZIP: 19805 FORMER COMPANY: FORMER CONFORMED NAME: Prelude Therapeutics Inc. DATE OF NAME CHANGE: 20160630 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-05-14 false 0001678660 Prelude Therapeutics Inc PRLD 0001752888 Lim Bryant David C/O PRELUDE THERAPEUTICS INCORPORATED 175 INNOVATION BOULEVARD WILMINGTON DE 19805 false true false false CLO, Interim CFO, Corp Sec. false Employee Stock Option (Right to Buy) 3.86 2024-05-14 4 A false 25000.00 0.00 A 2034-05-13 Common Stock 25000.00 25000.00 D The stock option vests as to 25% of the total shares on May 14, 2025, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. /s/ Krishna Vaddi, Attorney-in-Fact 2024-05-16